Despite no evidence of increased liver uptake of SARS‐CoV‐2 in NAFLD patients,25 in our study, the COVID‐19 cases with NAFLD had higher levels of alanine aminotransferase and aspartate aminotransferase than the other patients. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.